Crossmark

Factors associated with disability in patients with rheumatoid arthritis with persistent moderate disease activity: a retrospective cohort study

Published Online: 2020-10-21

Published Print: 2020-12

Authors

Scott, Ian C. http://orcid.org/0000-0002-1268-9808
Mount, Julie

Barry, Jane

Kirkham, Bruce
Funding

Funding for this research was provided by:

Eli Lilly and Company

National Institute for Health Research
License Information

Text and Data Mining valid from 2020-10-21

Version of Record valid from 2020-10-21
More Information

Article History

Received: 26 March 2020

Accepted: 19 August 2020

First Online: 21 October 2020

Ethics approval and consent to participate

: Analysis of data from Guy’s RA Centre was approved by the Health Research Authority (IRAS project ID 209418). As the Guy’s RA Centre comprises routinely collected anonymised healthcare data, written consent was not required.

: Not applicable.

: ICS has no competing interests; BK has received support from AbbVie, Arthritis Support UK, Eli Lilly and Company, Janssen, Novartis, F. Hoffmann-La Roche and UCB; JM is an employee of Eli Lilly and Company; JB was an employee of Eli Lilly and Company at the time of the study but is now an employee of Gilead Sciences.

Document is current